Urothelial Carcinoma TNM clinical staging
Item
patients have pathologically-proven urothelial carcinoma (uc) with a clinical stage <= t3n0m0
boolean
C2145472 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Urothelial Carcinoma Residual post treatment | Life Expectancy
Item
patients have no visible or identifiable residual uc after treatment with a life expectancy of > 6 months
boolean
C2145472 (UMLS CUI [1,1])
C1609982 (UMLS CUI [1,2])
C2709088 (UMLS CUI [1,3])
C0023671 (UMLS CUI [2])
Urothelium Remaining At risk Recurrence | Transplanted kidney Excluded
Item
patients have remaining urothelium at risk of recurrence (transplanted renal unit excluded)
boolean
C0227598 (UMLS CUI [1,1])
C1527428 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C0034897 (UMLS CUI [1,4])
C1261317 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
Malignant Neoplasm | primary tumor Treated Successful | primary tumor Cured | primary tumor remission
Item
no other active malignancy. patients who have other primary malignancies should be treated successfully prior to the study entry and should be in a cure or remission state for at least one year.
boolean
C0006826 (UMLS CUI [1])
C0677930 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C1272703 (UMLS CUI [2,3])
C0677930 (UMLS CUI [3,1])
C1880198 (UMLS CUI [3,2])
C0677930 (UMLS CUI [4,1])
C0544452 (UMLS CUI [4,2])
Able to swallow Lycopene Oral Capsule
Item
patients are able to take lycopene capsules orally.
boolean
C2712086 (UMLS CUI [1,1])
C1253418 (UMLS CUI [1,2])
Informed Consent | Compliance behavior | Blood specimen | Urine sample obtained | Tissue specimen
Item
patients who sign and give informed consents and are willing to conform to the scheduled sampling of the blood, urine and/or tissue
boolean
C0021430 (UMLS CUI [1])
C1321605 (UMLS CUI [2])
C0178913 (UMLS CUI [3])
C1277699 (UMLS CUI [4])
C1292533 (UMLS CUI [5])
TNM clinical staging | Neoplasm Metastasis
Item
patients who have clinical stage > t3n0m0 or metastatic disease
boolean
C3258246 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
Urine cytology Positive | diagnostic procedure Series | Echocardiography renal | Cystoscopy | Diagnostic ureterorenoscopy | imaging studies | Intravenous pyelogram | CT Urography | MRI of urinary tract | Retrograde pyelogram | Antegrade pyelography | Recurrent tumor | Residual Tumor
Item
positive urine cytology. patients who have positive cytology should be subjected to a serial diagnostic workup which may include renal echo, cystoscopy and ureterorenoscopy, and image studies (intravenous urography, computed tomography, magnetic resonance urography, retrograde or antegrade pyelography). if no recurrent or residual tumors are found, patients are still eligible for the study.
boolean
C2979983 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0430022 (UMLS CUI [2,1])
C0205549 (UMLS CUI [2,2])
C0013516 (UMLS CUI [3,1])
C0022646 (UMLS CUI [3,2])
C0010702 (UMLS CUI [4])
C1283825 (UMLS CUI [5])
C1881134 (UMLS CUI [6])
C0203108 (UMLS CUI [7])
C1504583 (UMLS CUI [8])
C1634512 (UMLS CUI [9])
C0203110 (UMLS CUI [10])
C0845988 (UMLS CUI [11])
C0521158 (UMLS CUI [12])
C0543478 (UMLS CUI [13])
Systemic Chemotherapy
Item
patients who have ever received systemic chemotherapy within 12 months
boolean
C1883256 (UMLS CUI [1])
Malabsorption gastrointestinal
Item
patients who have gastrointestinal malabsorption regardless of the etiology
boolean
C3714745 (UMLS CUI [1,1])
C0521362 (UMLS CUI [1,2])
Allergy to tomato | Allergic Reaction lycopene
Item
have known allergic reaction to tomato or lycopene
boolean
C1623747 (UMLS CUI [1])
C1527304 (UMLS CUI [2,1])
C0065331 (UMLS CUI [2,2])
Study Subject Participation Status
Item
patients who are participating or will participate in other clinical trials
boolean
C2348568 (UMLS CUI [1])
Urinary tract infection
Item
patients who have active urinary tract infection can not be accrued until infection is effectively controlled
boolean
C0042029 (UMLS CUI [1])
Age
Item
patient's age is less than 18 years
boolean
C0001779 (UMLS CUI [1])